Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 11 Jul 2022 for Entasis Therapeutics Holdings Inc., €121k.
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Manoussos Perros: trading record in brief
This profile gathers the share dealings of Manoussos Perros in Entasis Therapeutics Holdings Inc., where the filings describe the role as chief executive. Between 15 January 2021 and 11 July 2022, the trades on record add up to 7 filings.
The open-market record consists of 1 sale worth €33k, with no purchase. Other entries cover 4 share grants.
On 11 July 2022 came the latest disclosure, a transaction in Entasis Therapeutics Holdings Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Manoussos Perros
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
56,072 shares@ US$2.2067.2% of flowCommon StockSEC:0001104659-22-078800:0
125,000 shares0Common StockSEC:0001104659-22-005423:0
11,704 shares@ US$2.9419.7% of flowCommon StockSEC:0001104659-21-133627:0
79,750 shares0Common StockSEC:0001104659-21-128067:0
4 of 4 declarations
